Funding
OncoMind AI
Synagen is working on “OncoMind AI”.
An AI-supported decision aid for oncological treatment decisions.
Goal: better-substantiated decision bases for physicians in cancer therapy.
Funded as part of the R&D single-project funding scheme (FRL EFRE/JTF technology funding).

